Onset of efficacy and duration of response of galcanezumab for the prevention of episodic migraine: a post-hoc analysis

BACKGROUND AND OBJECTIVE: As new migraine prevention treatments are developed, the onset of a preventive effect, how long it is maintained and whether patients initially non-responsive develop clinically meaningful responses with continued treatment can be assessed. METHODS: Analyses were conducted...

Descripción completa

Detalles Bibliográficos
Autores principales: Goadsby, Peter J, Dodick, David W, Martinez, James M, Ferguson, Margaret B, Oakes, Tina M, Zhang, Qi, Skljarevski, Vladimir, Aurora, Sheena K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Migraine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691875/
https://www.ncbi.nlm.nih.gov/pubmed/31004075
http://dx.doi.org/10.1136/jnnp-2018-320242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691875/
https://www.ncbi.nlm.nih.gov/pubmed/31004075
http://dx.doi.org/10.1136/jnnp-2018-320242

Ejemplares similares